Amlodipine Besylate; Benazepril Hydrochloride Capsule
Brand: LOTREL
This drug is currently listed as to be discontinued by the FDA. Affected manufacturer: Novartis Pharmaceuticals Corporation.
Amlodipine Besylate; Benazepril Hydrochloride Capsule is in the FDA Drug Shortage Database with a status of To Be Discontinued.
The FDA Drug Shortage Database lists Amlodipine Besylate; Benazepril Hydrochloride Capsule with a status of To Be Discontinued from Novartis Pharmaceuticals Corporation (Capsule). Therapeutic category: Cardiovascular.
Active FDA Drug Shortage
Contact your pharmacist if you are affected. They can check availability from other manufacturers or suggest alternatives.
Shortage Details
- Generic Name
- Amlodipine Besylate; Benazepril Hydrochloride Capsule
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Capsule
- Presentation
- Lotrel, Capsule, 10 mg; 40 mg (NDC 0078-0379-05)
- Package NDC
- 0078-0379-05
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jun 24, 2025
- Last Updated
- Jun 24, 2025
- Therapeutic Category
- Cardiovascular
Shortage Reason
Permanent discontinuation in the manufacturing of the drug
Full Drug Profile
amlodipine
Side effects, interactions, warnings & more
Nearby, Other Amlodipine Shortage Records
Amlodipine Besylate; Benazepril Hydrochloride Capsule
Novartis Pharmaceuticals Corporation
Capsule
Amlodipine Besylate; Benazepril Hydrochloride Capsule
Novartis Pharmaceuticals Corporation
Capsule
Amlodipine Besylate; Benazepril Hydrochloride Capsule
Novartis Pharmaceuticals Corporation
Capsule
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet
Torrent Pharma Inc.
Tablet
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet
Torrent Pharma Inc.
Tablet
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet
Torrent Pharma Inc.
Tablet
Frequently Asked Questions
Why is Amlodipine in shortage?
What can I do if my medication is in shortage?
How often is this data updated?
What This Amlodipine Shortage Record Means
The FDA Drug Shortages database lists this record for Amlodipine Besylate; Benazepril Hydrochloride Capsule (brand: LOTREL) from Novartis Pharmaceuticals Corporation with a current status of To Be Discontinued. The affected dosage form is Capsule, presented as Lotrel, Capsule, 10 mg.
This shortage was first reported on Jun 24, 2025 and was last updated Jun 24, 2025. The FDA cites the following reason: Permanent discontinuation in the manufacturing of the drug. There are 6 other current records in this database covering the same generic, which gives a fuller picture of how disruption is playing out across manufacturers and dosage forms.
What a shortage listing does (and doesn't) mean
Shortages are tracked at the manufacturer and presentation level, other manufacturers or formulations of the same generic may remain available, which is why pharmacists often can source a working substitute even when one record is flagged. A shortage listing is a supply-side signal, not a patient-level instruction. Access can vary dramatically by pharmacy, region, hospital system, and insurance formulary, local pharmacists have real-time visibility that a national database cannot provide. Therapeutic substitutes often exist in the same class, but switching decisions belong with your prescriber, who weighs efficacy, dosing conversion, interaction profile, and personal history. This page summarizes public FDA data for educational reference only and is not medical advice. If your medication is affected, contact your pharmacist and prescriber to plan an appropriate response.
Disclaimer: This information comes from the FDA Drug Shortages Database and is for educational purposes only. It is not medical advice. Do not stop or change any medication without consulting your healthcare provider or pharmacist. Shortage status can change rapidly, always verify current availability with your pharmacist.
Read our methodology - how this data is sourced, computed, and verified.